The Veterinary Antibiotics Market Size is valued at USD 4898.48 Million in 2023 and is predicted to reach USD 6316.37 Million by the year 2031 at a 3.34 % CAGR during the forecast period for 2024-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1128
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global veterinary antibiotics market are:
- Rising popularity of pet insurance
- Increase in animal health issues
- Rising awareness of veterinary illnesses
The following are the primary obstacles to the veterinary antibiotics market’s expansion:
- Huge increase in the price of veterinary antibiotics
- Shortage of qualified veterinarians
- Strong competition
Future expansion opportunities for the global veterinary antibiotics market include:
- Increasing numbers of domesticated animals
- Rising public consciousness
- Rising disposable income
Market Analysis:
The demand is anticipated to rise due to the growing demand for companion animals and the increasing preference of consumers for various dairy products. Demand is expected to be further bolstered during the predicted period due to an increase in animal disease outbreaks and activities aimed at improving the health and well-being of animals. In addition, the market is being driven by factors such as the increasing number of recovered animals, healthcare spending on animal care, and the facilities of veterinary antibiotics. Furthermore, the rising incidence of animal diseases and the introduction of new rules are meant to curb the spread of infectious illnesses in animals. This market is anticipated to experience expansion due to factors such as the increasing demand for pet insurance and the rising costs of veterinary healthcare.
List of Prominent Players in the Veterinary Antibiotics Market:
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Sante Animale S.A.
- Crystal Pharma
- Dechra Pharmaceuticals PLC
- Huvepharma AD
- Eli Lilly Company
- Elanco
- Merck & Co., Inc.
- Sanofi S.A.
- Vetoquinol S.A.
- Virbac
- Zoetis, Inc.
- Inovet Group
- Dopharma
- Others
Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1128
Recent Developments:
- In Aug 2023, Bayer introduced the AMR Action Fund, an innovative collaboration aimed at delivering 2-4 novel antibiotics to patients by 2030. These medicines are necessary in order to combat the exponential increase of antibiotic-resistant infections, often known as antimicrobial resistance or AMR.
- In March 2022, Merck Animal Health got approval from the U.S. Food and Drug Administration for NUFLOR-S (florfenicol) Injectable Solution and AROVYN (tulathromycin injection). These are prescription antibiotics with a wide range of uses that kill the main bacteria that cause pig respiratory disease.
Veterinary Antibiotics Market Dynamics:
Market Drivers: Increasing Issues Regarding the Welfare of Animals
The increasing well-being of pets is a major driver of the global market. More and more people are worried about the well-being of animals. The primary driver propelling the expansion of this market is the anticipated surge in the demand for veterinary antibiotics, brought about by the increasing expenditure on veterinary care and the popularity of pet insurance. There will likely be a multiplicative effect on the market’s expansion due to rising zoonotic disease cases and government programs aimed at improving animals’ health and welfare. The consistent and fast-paced increase in the consumption of meat and seafood is another factor driving the veterinary antibiotics market expansion. The increasing demand for food products generated from animals is expected to increase the market’s expansion.
Challenges: Strict Evaluation Procedure and Lack of Skilled Workers
Several restrictions hinder the anticipated growth of the global market. The market expansion is anticipated to be impeded by the stringent approval method for veterinary antibiotics. In addition, throughout the projection period, the veterinary antibiotics market is expected to face challenges from factors such as the scarcity of novel antibiotics and the replacement of antibiotics used for preventative purposes by effective husbandry and sanitization techniques. Furthermore, veterinary antibiotic medicines are costly. With pet insurance, these expenses can be manageable for animal owners. In addition, the spread of veterinary antibiotics could be hindered by legislative restrictions. Furthermore, there needs to be more qualified individuals with veterinary antibiotics services, which also hampers market growth.
North America Is Expected To Grow With The Highest CAGR During The Forecast Period
The North American veterinary antibiotics market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of the growing number of animals in the area, the need for foods made from animals, the popularity of pet insurance, and the costs associated with animal healthcare, which has led to the widespread usage of veterinary antibiotics, propelling the market growth. Additionally, the area’s medical system is rapidly expanding, and consumer awareness of animal care is rising. Furthermore, veterinary antibiotics are expected to be more widely used during the projected period due to rising awareness of veterinary diseases and an increase in animal health issues.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1128
Segmentation of Veterinary Antibiotics Market-
By Product Type –
- Tetracycline
- Penicillins
- Sulfonamides
- Macrolides
- Aminoglycosides
- Lincosamides
- Fluoroquinolones
- Other Antimicrobials & Antibiotics
By Mode of Delivery-
- Premixes
- Oral Powder
- Oral Solution
- Injection
- Others
By Animal Type-
- Food-Producing Animals
- Cattle
- Pigs
- Poultry
- Sheep and Goats
- Other Food-producing Animals
- Companion Animals
- Dogs
- Cats
- Horses
- Other Companion Animals
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Details insights on this market: https://www.insightaceanalytic.com/report/global-veterinary-antibiotics-market-/1128
Contact Us:
[email protected]
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Information:
Email: [email protected] North America: +1 551 226 6109 Asia: +91 79 72967118 InsightAce
Tags:
BNN, Extended Distribution, Go Media, iCN Internal Distribution, IPS, Research Newswire, English